Klebsiella pneumoniae: Epidemiology and analysis of risk factors for infections caused by resistant strains

Chinese Medical Journal

Volumn 115, Issue 8, 2002, Pages 1158-1162

  Li, Jiabin ^a   Ma, Yilin ^a   Wang, Zhongxin ^a   Yu, Xinzhi ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Antibiotics; Epidemiology; Klebsiella pneumoniae; Resistance; Risk factors

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE DERIVATIVE; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFALOTIN; CEFAZOLIN; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MACROLIDE; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TAZOBACTAM; TIMENTIN; TOBRAMYCIN; UNINDEXED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATION; CHILD; COMMUNITY; CONTROLLED STUDY; DRUG UTILIZATION; ENTEROBACTER INFECTION; FEMALE; HOSPITAL INFECTION; HUMAN; INFANT; INFECTION RISK; KLEBSIELLA PNEUMONIAE; MALE; NONHUMAN; RETROSPECTIVE STUDY; DRUG EFFECT; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMAN; INFANT; INFANT, NEWBORN; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGE; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; HUMANS; MIDDLE AGED;

EID: 0036686114     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Drug resistance among clinical isolates of frequently encountered bacterial species in central Europe during 1975 - 1995
2. Escherichia coli: Epidemiology and analysis of risk factors for infections caused by resistant strains
3. Extended-spectrum beta-lactamases: A call for improved detection and control
4. Surveillance of nosocomial infections: A fundamental ingredient for quality
5. CDC definitions for nosocomial infections, 1988
6. Spread of extended-spectrum β-lactamases producing Klebsiella pneumoniae: Are β-lactamases inhibitors of therapeutic value?
7. Fluoroquinolone use and fluoroquinolone resistance: Is there an association?
8. Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin
9. Monitoring and control of infection in patients after renal transplantation
10. Antimicrobial resistance-pharmacological solutiouns
11. Hospital outbtrak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and β-lactamase inhibitor combinations by hyperproduction of SHV-5β-lactamase
12. Molecular genetics of resistance to both ceftazidime and β-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to β-lactam therapy
13. Effect of hyperproduction of TEM-1 β-lactamase on in vitro susceptibility of Escherichia coli to β-lactam antibiotics
14. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum cephalosporins
15. Indications for antibiotic use in ICU patients: A one year prospective surveillance
16. Short course empiric antibiotic therapy for suspected nosocomial pneumonia: A proposed solution for indiscriminate antibiotic prescription for pulmonary infiltrates in the ICU
17. Prevalence and analysis of risk factors for infections caused by resistant Escherichia coli strains in Anhui, China